Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$75.47 - $135.88 $2.74 Million - $4.94 Million
-36,322 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$95.64 - $131.48 $1.29 Million - $1.77 Million
-13,486 Reduced 27.08%
36,322 $3.89 Million
Q2 2021

Aug 12, 2021

BUY
$88.13 - $142.06 $3.89 Million - $6.28 Million
44,185 Added 785.79%
49,808 $6.64 Million
Q1 2021

May 13, 2021

BUY
$105.48 - $207.97 $435,843 - $859,332
4,132 Added 277.13%
5,623 $696,000
Q4 2020

Feb 16, 2021

SELL
$76.64 - $167.89 $171,520 - $375,737
-2,238 Reduced 60.02%
1,491 $211,000
Q3 2020

Nov 12, 2020

BUY
$45.46 - $78.79 $169,520 - $293,807
3,729 New
3,729 $283,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.38B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.